Dr. Musa Marimani

Musa Marimani is a microbiologist whose research centers on antimicrobial resistance, microbial pathogenesis, and host–pathogen interactions. His work integrates molecular biology, genomics, and bioinformatics to investigate how bacteria and fungi evade conventional therapies. He has contributed to studies on Vibrio cholerae in environmental waters, highlighting genomic traits, virulence factors, and resistance determinants relevant to public health surveillance.

A major theme in his scholarship is the role of epigenetic regulation in tuberculosis and TB–HIV co-infection, examining how host gene expression and microbial factors influence disease progression and drug resistance. His analyses of antioxidant defense systems in Candida species and the modulation of oxidative stress pathways reveal mechanisms underpinning antifungal resistance and identify potential therapeutic targets.

Marimani also explores non-traditional antimicrobial strategies, including plant-derived compounds, quorum sensing inhibitors, nanoemulsion-based drug delivery systems, and advanced therapeutic approaches to counter multidrug-resistant pathogens. Across these areas, his work demonstrates strength in translational microbiology, bridging laboratory investigation with strategies aimed at improving infectious disease control and treatment.